PREVALENCE OF MICROALBUMINURIA IN TYPE - 2 DIABETES MELLITUS: A HOSPITAL BASED STUDY

Dharamveer Yadav; Bhawani Kochar; Ankur Mathur; Arun Chougle

doi:10.29121/granthaalayah.v5.i12.2017.496

Authors

Dharamveer Yadav Department of Biochemistry, SMS Medical College and Hospital, Rajasthan University of Health Sciences, Jaipur, India
Bhawani Kochar Department of Biochemistry, SMS Medical College and Hospital, Rajasthan University of Health Sciences, Jaipur, India
Ankur Mathur Department of Biochemistry, SMS Medical College and Hospital, Rajasthan University of Health Sciences, Jaipur, India
Arun Chougle Department of Radiological Physics, SMS Medical College and Hospital, Rajasthan University of Health Sciences, Jaipur, India

DOI:

https://doi.org/10.29121/granthaalayah.v5.i12.2017.496

Keywords:

Type-2 Diabetes Mellitus, Glycosylated Haemoglobin, Blood Glucose, Diabetic Nephropathies

Abstract [English]

Aim: Microalbuminuria (MAU) has been shown to be a risk factor for nephropathy in patients with type 2 diabetes. In this study, we aimed to explore the association between MAU and other risk factors in the development of diabetic nephropathy with type 2 diabetes.

Methods: Five twenty one patients with type 2 diabetes were recruited in this study. Medical records were used to collect data of age, duration of diabetes, Body Mass Index (BMI) and history of hypertension. Blood samples were collected after 12 hours overnight fasting to estimate fasting blood glucose (FBG), Glycosylated haemoglobin (HbA1C), serum creatinine, and serum uric acid. MAU was quantified using the dipstick method in early morning urine samples.

Results: Out of 521 subjects 37.5% (186 subjects) were found to be suffering from MAU. Systolic and diastolic blood pressure (p<0.001), HbA1C (p<0.001) and fasting blood glucose (p<0.001) were significantly higher in subjects with MAU as compared to normoalbuminuria subjects. Further, on multiple logistic regression analysis it was observed that duration of diabetes, systolic and diastolic blood pressure, serum creatinine and FBG are associated with MAU.

Conclusion: The overall prevalence of the MAU was high in the present study, which necessitates for early detection of nephropathy to reduce the burden of diabetes induced kidney disease in the future.

Downloads

Download data is not yet available.

References

Suryawanshi KS, Jagtap PE, Belwalkar GJ, Dhonde SP, Nagane NS, Joshi VS.To study serum uric acid and urine microalbumin in type-2 diabetes mellitus. SSRG Int J Med Sci 2015; 2(3):24-9.

King H, Aubert RE, Herman WH. Global burden of Diabetes, 1995-2025: Prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-31. DOI: https://doi.org/10.2337/diacare.21.9.1414

Vishwanathan V. Type 2 diabetes and diabetic nephropathy in India- Magnitude of the problem. Nephrol Dial Transplant 1999; 14:2805-07. DOI: https://doi.org/10.1093/ndt/14.12.2805

Cordonnier D, Bayle F, Benhamou PY, Milongo R, Zaoni P, Maynard C et al. Future trends of management of renal failure in diabetics. Kidney Int suppl.1993; 41:S8–13.

US Renal Data System. 1989 Annual data report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 1989.

Mogensen CE,Steffes MW, Deckert T, Christiansen JS.Functional and morphological renal manifestations in diabetes mellitus. Diabetologia 1981; 21:89–93. DOI: https://doi.org/10.1007/BF00251272

Viberti GC,Keen H.The patterns of proteinuria in diabetes mellitus: relevance of pathogenesis and prevention of diabetic nephropathy. Diabetes 1984; 33: 686-92. DOI: https://doi.org/10.2337/diab.33.7.686

Alzaid AA. MAU in patients with NIDDM: an overview. Diabetes Care 1996; 19:79–89. DOI: https://doi.org/10.2337/diacare.19.1.79

Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F et al. Prevalence and causes of albuminuria in non-insulin dependent diabetic patients. Kidney Int 1990; 41:758–62. DOI: https://doi.org/10.1038/ki.1992.118

Jong PE, Hillege HL, Joan PS, Zeeuw D. Screening for MAU in the general population: A tool to detect subjects at increased risk for progressive renal failure in an early phase.Nephrol Dial Transpl 2003; 18:10-13. DOI: https://doi.org/10.1093/ndt/18.1.10

Hiddo J, Heerspink L, Holtkamp F, Ravid M. Monitoring kidney function and albuminuria in patients with diabetes. Diabetes Care 2011; 34: 325-9. DOI: https://doi.org/10.2337/dc11-s247

American Diabetes Association. Standards of medical care in diabetes—2016. Diabetes Care. 2016; 39 (suppl 1):S1-106. DOI: https://doi.org/10.2337/dc16-S003

Trinder, P. Determination of blood glucose using an oxidase peroxidase system with a non-carcinogenic chromogen. JClin Pathol 1969; 22: 158-61. DOI: https://doi.org/10.1136/jcp.22.2.158

Praetorius E, Poulson H. Enzymatic determination of uric acid; with detailed directions. Scand J Clin lab Inv 1953; 5(3): 273-80. DOI: https://doi.org/10.3109/00365515309094197

Bonsnes RW, Taussky HH. On the colorimetric determination of creatinine by the Jaffe reaction. J Biol Chem 1945, 158: 581-91.

Gupta DK, Verma LK, Khosla PK, Dash SC. The prevalence of MAU in diabetes: a study from north India. Diabetes Res Clin Pr 1991; 2: 125–8. DOI: https://doi.org/10.1016/0168-8227(91)90089-V

John L, Rao PS, Kanagasabapathy AS. Prevalence of diabetic nephropathy in non-insulin dependent diabetes. Indian J Med Res 1991; 94: 24–9.

Vijay V,Snehalatha C, Ramachandran A, Viswanathan M.Prevalence of proteinuria in non-insulin dependent diabetes. J Assoc Physician I 1994; 42:792–4.

Ronald Klein, Barbara EK, Scot E Moss. Prevalence of MAU in older -onset diabetes. Diabetes Care 1993; 16(10): 1325-30. DOI: https://doi.org/10.2337/diacare.16.10.1325

Agrawal R, Phogawat M ,Agrawal RP. Prevalence of Nephropathy and Its Risk Factors in Type -2 Diabetes: A Tertiary -Care Hospital Based Study. RUHS J Health Sci 2016; 1(1): 20-3. DOI: https://doi.org/10.37821/ruhsjhs.1.1.2016.20-23

Viswanathan VV, Snehalatha C, Ramchandran A, Viswanathan M. Proteinuria in NIDDM in South India. Analysis of predictive factors. Diab Res Clin Pract 1995; 28: 41-6. DOI: https://doi.org/10.1016/0168-8227(95)01057-K

Rema M, Ponnaiya M, Mohan V. Prevalence of retinopathy in non-insulin dependent diabetes mellitus at a diabetes centre in Southern India. Diab Res Clin Pract 1996; 34: 29-36. DOI: https://doi.org/10.1016/S0168-8227(96)01327-7

Ramchandran A, Snehalatha C, Satyavani K, Latha E, Sasikala R, Vijay V. Prevalence of vascular complications and their risk factors in type 2 diabetes. J Assoc Physician I 1999; 47: 1152-6.